Hiroki Oikawa
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Epidemiology 10
- Liver Disease Diagnosis and Treatment 5
- Co-authors
- Tomoyuki Masuda (25 shared papers)Chihaya Maesawa (10 shared papers)Masahiko Shibazaki (5 shared papers)Go Wakabayashi (2 shared papers)Hideaki Komatsu (2 shared papers)Kuniyuki Kato (2 shared papers)Akiko Yashima‐Abo (2 shared papers)Ryoichi Satodate (6 shared papers)
- Journals
- Pathology International (3 papers)Journal of Gastroenterology and Hepatology (3 papers)Scientific Reports (2 papers)Review of Scientific Instruments (2 papers)The Anatomical Record (2 papers)
- Partner nations
- JapanUnited StatesGreece
In The Last Decade
Hiroki Oikawa
50 papers receiving 806 citations
Peers
Comparison fields: 5 of 110
- Cancer Research 197
- Hepatology 99
- Oncology 136
- Molecular Biology 332
- Dermatology 42
Countries citing papers authored by Hiroki Oikawa
This map shows the geographic impact of Hiroki Oikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Oikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Oikawa more than expected).
Fields of papers citing papers by Hiroki Oikawa
This network shows the impact of papers produced by Hiroki Oikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Oikawa. The network helps show where Hiroki Oikawa may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroki Oikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 220 | |
| 2 | 1999 | 53 | |
| 3 | 2005 | 47 | |
| 4 | 2000 | 46 | |
| 5 | 1998 | 41 | |
| 6 | 2008 | 38 | |
| 7 | 2009 | 35 | |
| 8 | 1997 | 30 | |
| 9 | 2015 | 27 | |
| 10 | 1997 | 26 | |
| 11 | 2005 | 26 | |
| 12 | 2015 | 24 | |
| 13 | 2011 | 22 | |
| 14 | 2016 | 16 | |
| 15 | 2010 | 14 | |
| 16 | 2014 | 13 | |
| 17 | 1998 | 12 | |
| 18 | 2015 | 12 | |
| 19 | 2019 | 9 | |
| 20 | 2020 | 9 |
About Hiroki Oikawa
Hiroki Oikawa is a scholar working on Molecular Biology, Epidemiology, Hepatology, Surgery and Biomedical Engineering, having authored 52 papers that have together received 833 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Liver Disease and Transplantation (4 papers), Liver physiology and pathology (3 papers), Particle accelerators and beam dynamics (3 papers), Sarcoma Diagnosis and Treatment (3 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Orbital Angular Momentum in Optics (2 papers). The work is most often cited by research in Cancer Research (197 citations), Hepatology (99 citations), Oncology (136 citations), Molecular Biology (332 citations) and Dermatology (42 citations). Hiroki Oikawa has collaborated with scholars based in Japan, United States and Greece. Frequent co-authors include Tomoyuki Masuda, Chihaya Maesawa, Masahiko Shibazaki, Go Wakabayashi, Hideaki Komatsu, Kuniyuki Kato, Akiko Yashima‐Abo, Ryoichi Satodate, Takeshi Iwaya and Satoshi Ogasawara. Their work appears in journals such as Pathology International, Journal of Gastroenterology and Hepatology, Scientific Reports, Review of Scientific Instruments and The Anatomical Record.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.